Abstract

The Contractor shall develop and optimize PLAC1 with or without IL12 in either/or DNA-based plasmid or replication deficient virus like recombinant vaccinia vectors. Vaccines in these two diverse delivery vectors should be tested in a head-to-head comparison for efficacy in two GEM models, MMTV-PPARand BRCA1ex11/p53+/- mice.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
261201200018I-0-26100002-1
Application #
8563974
Study Section
Project Start
2012-09-20
Project End
2014-09-19
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$698,588
Indirect Cost

  Institution

Name
Weill Medical College of Cornell University
Department
Type
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065